Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference | ||
By: PR Newswire Association LLC. - 07 Feb 2024 | Back to overview list |
|
HAMILTON, ON and BOSTON, Feb. 7, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present virtually at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Wednesday, February 14, 2024, at 10:00 a.m. ET. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D. A webcast of the event will be available on the "Events and Presentations" page in the "Investors & Media" section of the Company's website at https://ir.fusionpharma.com/events-webcasts. A replay of the webcast will be archived on the Company's website for 90 days following the presentation date. About Fusion Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-to-present-at-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302055615.html SOURCE Fusion Pharmaceuticals |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |